RT Journal Article
SR Electronic
T1 Self-harm presentations to Emergency Departments and Place of Safety during the ‘first wave’ of the UK COVID-19 pandemic: South London and Maudsley data on service use from February to June 2020
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.12.10.20247155
DO 10.1101/2020.12.10.20247155
A1 Nuzum, Eleanor
A1 Martin, Evangelia
A1 Morgan, Gemma
A1 Dutta, Rina
A1 Mueller, Christoph
A1 Polling, Catherine
A1 Pritchard, Megan
A1 Velupillai, Sumithra
A1 Stewart, Robert
YR 2020
UL http://medrxiv.org/content/early/2020/12/14/2020.12.10.20247155.abstract
AB The lockdown and social distancing policy imposed due to the COVID-19 pandemic has had a substantial impact on both mental health service delivery, and the ways in which people are accessing these services. Previous reports from the South London and Maudsley NHS Trust (SLaM; a large mental health service provider for around 1.2m residents in South London) have highlighted increased use of virtual contacts by mental health teams, with dropping numbers of face-to-face contacts over the first wave of the pandemic. There has been concern that the impact of the COVID-19 pandemic would lead to higher mental health emergencies, particularly instances of self-harm. However, with people advised to stay at home during the ‘first wave’ lockdown, it is as yet unclear whether this impacted mental health service presentations. Taking advantage of SLaM’s Clinical Records Interactive Search (CRIS) data resource with daily updates of information from its electronic mental health records, this paper describes overall presentations to Emergency Department (ED) mental health liaison teams, and those with self-harm. The paper focussed on three periods: i) a pre-lockdown period 1st February to 15th March, ii) a lockdown period 16th March to 10th May and iii) a post-lockdown period 11th May to 28th June. In summary, all attendances to EDs for mental health support decreased during the lockdown period, including those with self-harm. All types of self-harm decreased during lockdown, with self-poisoning remaining the most common. Attendances to EDs for mental health support increased post-lockdown, although were only just approaching pre-lockdown levels by the end of June 2020.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe research leading to these results has received support from the Medical Research Council Mental Health Data Pathfinder Award to Kings College London, and a grant from Kings Together. RS, RD, CM, MP and SV are part-funded by the National Institute for Health Research (NIHR) Biomedical Research Centre at the South London and Maudsley NHS Foundation Trust and Kings College London; RS is additionally part-funded by: i) a Medical Research Council (MRC) Mental Health Data Pathfinder Award to Kings College London; ii) an NIHR Senior Investigator Award; iii) the National Institute for Health Research (NIHR) Applied Research Collaboration South London (NIHR ARC South London) at Kings College Hospital NHS Foundation Trust. EN and EM are supported by the DETERMIND project, funded by the Economic and Social Research Council (UK) and the National Institute for Health Research (UK); grant number ES/S010351/1. RD is funded by a Clinician Scientist Fellowship (research project e-HOST-IT) from the Health Foundation in partnership with the Academy of Medical Sciences. CP is funded by a Wellcome Trust Research Training Fellowship (Reference 105757/Z/14/Z). The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, the MRC, the Department of Health and Social Care, the ESRC or Kings College London.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Oxford REC C reference 18/SC/0372All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesIndividual patient data are required to remain within the secure network of the data provider, but can be made accessible on request from the corresponding author and subject to data provider information governance approval.